Mediwound share price logo

Mediwound

NASDAQ: MDWD

$12.66

-0.58

(-4.38%)

as on

Mediwound Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $12.52
    $13.15
    downward going graph

    1.11%

    Downside

    3.87%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.61
    $20.30
    downward going graph

    0.39%

    Downside

    60.35%

    Upside

    downward going graph

Mediwound share price movements today

Previous Close
$13.24
Open
$13.04
Volume
386.8K
Market Cap
$164.0M
Day's Low - High
$12.52 - $13.15
52 Week Low - High
$12.61 - $20.30

Mediwound Historical Returns

1 Month Return
-9.44 %
3 Month Return
-9.07 %
1 Year Return
-21.28 %
3 Year Return
+ 50.45 %
5 Year Return
-47.02 %

Mediwound Stock Fundamentals & Key Indicators

Check Mediwound market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$164.0M

EPS (TTM)

-1.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-8.11

Industry PE ratio

-1.6366929133858268

PEG Ratio

-0.22069620627381195

EBITDA

-19.0M

Revenue (TTM)

11.9M

Profit Margin

15.46%

Return On Equity TTM

-47.24%

Mediwound Stock Valuation

Track how Mediwound P/E has moved over time to understand its valuation trends.

Mediwound in the last 5 years

  • Overview

  • Trends

Lowest (-13.65x)

December 31, 2023

Today (-8.79x)

December 31, 2025

Industry (-1.64x)

December 31, 2025

Highest (-3.43x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -8.79x

Mediwound vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mediwound with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$164.0M-47.02%-8.1115.46%NA
BUY$46.2B675.69%NA0.00%NA
BUY$138.7B173.88%31.9286.04%NA
BUY$59.7B-62.65%-7.98-12.57%NA
BUY$85.8B21.77%19.984.86%0.44%

Stock Returns calculator for Mediwound Stock including INR - Dollar returns

The Mediwound stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mediwound investment value today

Current value as on today

₹81,950

Returns

-₹18,050

(-18.05%)

Returns from Mediwound Stock

-₹24,732 (-24.73%)

Dollar Impact

₹6,683 (+6.68%)

Analyst Recommendation on Mediwound Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Mediwound. Average target price of $29.83

Mediwound Share Price Target

Get share price movements and forecasts by analysts on Mediwound.

What analysts predicted

57.56%UPSIDE

Target Price

$29.83

Current Price

$12.66

Analyzed by

5 Analysts

Target

$29.83

Mediwound target price $29.83, a slight upside of 57.56% compared to current price of $12.66. According to 5 analysts rating.

Indian Investors' Interest in Mediwound Stock

Search interest for Mediwound Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:18% versus previous 30 day period

Mediwound Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
4
5
4
5
3
5
5
1
1
3
Gross Profit
0
0
0
0
0
1
0
0
0
0
Operating Income
-3
-4
-5
-6
-5
-5
-6
-7
-7
-9
EBITDA
-3
-3
-4
-15
0
-4
-2
-5
-2
-9
Interest Expense
5
2
5
-
-
7
-
-
-
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-6
-10
-3
0
-13
-2
-7
-2
-7
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-9
-6
-10
-3
0
-13
-2
-7
-2
-7
Net Profit Margin
12.23%
8.83%
15.55%
15.46%
18.66%
23.51%
16.50%
14.89%
21.90%
10.90%

Mediwound Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
3
31
21
23
26
18
20
16
Gross Profit
0
1
19
7
8
13
3
2
3
Operating Income
-13
-3
4
-8
-11
-7
-15
-19
-25
EBITDA
-13
-4
4
-7
-11
-18
-4
-27
-21
Interest Expense
-
-
0
0
0
0
0
0
0
Depreciation
0
0
1
1
1
1
1
1
1
Income Before Tax
-14
-5
2
-9
-13
-19
-6
-30
-23
Income Tax Expense
-
-
-
-
0
0
0
0
0
Net Income
-22
-1
4
-9
-13
-19
-6
-30
-23
Net Profit Margin
32.37%
35.58%
60.72%
32.21%
34.24%
46.50%
15.77%
13.03%
19.19%

Mediwound Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-6
-10
-3
0
-13
-2
-7
-2
-7
Operating Cash Flow
-4
-3
-3
-1
-4
-5
-3
-3
-6
-8
Investing Cash Flow
-2
2
-14
4
-3
4
4
-23
17
-2
Financing Cash Flow
0
0
20
0
0
0
30
-1
0
0
Change in Cash
23
0
2
2
-7
0
31
-27
10
-40

Mediwound Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-1
4
-9
-13
-19
-6
-30
-23
Operating Cash Flow
-16
-12
8
-6
-8
-11
-10
-13
-14
Investing Cash Flow
0
-17
-6
17
3
0
-34
-8
-19
Financing Cash Flow
22
0
-1
0
-1
35
22
19
29
Change in Cash
7
-29
0
10
-6
22
-22
-2
-4

Mutual Funds that own Mediwound Stock

Check out the Mutual Funds with significant holdings in Mediwound.

Funds
Holdings
Shares Held
T. ROWE PRICE NEW HORIZONS FUND, INC.
1.907627%
246280
T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.
1.514816%
195567
Fidelity Salem Street Trust
0.803956%
103793
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
0.481639%
62181
VANGUARD SCOTTSDALE FUNDS
0.444157%
57342

Global Institutional Holdings in Mediwound

Funds
Holdings
iShares
2.92%
ARK
1.14%
Cathie Wood
0.98%
Vanguard
0.54%
SPDR
0.31%

Insights on Mediwound

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MDWD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.47M → 3.09M (in $), with an average increase of 52.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 472.8% return, outperforming this stock by 497.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MDWD stock has moved down by -11.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -2.95M → -7.39M (in $), with an average decrease of 150.4% per quarter

About Mediwound

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
OrganisationMediwound
Headquarters42 Hayarkon Street, Yavne, Israel, 8122745
IndustryBiotechnology
CEOMr. Ofer Gonen B.Sc.
E-voting on sharesClick here to vote

Key Management of Mediwound

Name

Title

Dr. Liron Gal

Vice President of Manufacturing Science & Technology

Mr. Barry J. Wolfenson

Executive Vice President of Strategy & Corporate Development

Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.

Senior Vice President of Global Medical Affairs

Mr. Ofer Gonen B.Sc.

Chief Executive Officer

Ms. Hani Luxenburg

Chief Financial Officer

Dr. Shmulik Hess Ph.D.

COO & Chief Commercial Officer

Mr. Yaron Meyer Adv.

Executive VP, General Counsel & Corporate Secretary

Dr. Ety Klinger MBA, Ph.D.

Chief Medical Officer

FAQs

What is Mediwound share price today?

Mediwound share price today is $12.66 as on at the close of the market. Mediwound share today touched a day high of $13.15 and a low of $12.52.

What is the 52 week high and 52 week low for Mediwound share?

Mediwound share touched a 52 week high of $20.30 on and a 52 week low of $12.61 on . Mediwound stock price today i.e. is closed at $12.66,which is 37.64% down from its 52 week high and 0.40% up from its 52 week low.

What is Mediwound's market capitalisation today?

Mediwound market capitalisation is $0.00T as on .

How to invest in Mediwound Stock (MDWD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mediwound on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mediwound Shares that will get you 0.1185 shares as per Mediwound share price of $12.66 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Mediwound Stock (MDWD) from India?

Indian investors can start investing in Mediwound (MDWD) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in Mediwound stock (as per the Rupee-Dollar exchange rate as on ). Based on Mediwound share’s latest price of $12.66 as on August 29, 2026 at 8:46 am IST, you will get 0.7899 shares of Mediwound. Learn more about fractional shares .

What are the returns that Mediwound has given to Indian investors in the last 5 years?

Mediwound stock has given -47.02% share price returns and 30.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?